ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 744449 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 744449; 2) Community: the network communities that were significantly associated with the response to NSC 744449; 3) Molecule: the relationships between components within communities and NSC 744449; 4) MDR: the compounds that were significantly associated with the NSC 744449.

NSC Compound Enrichment Correlation
NSC 105014 Cladribine 0.0490935610249067 -0.22483996
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0490935610249067 -0.27594015
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0490935610249067 -0.2135764
NSC 163443 Null 0.0490935610249067 -0.016469643
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0490935610249067 -0.20592146
NSC 300289 Pinafide 0.0490935610249067 0.078209957
NSC 303812 Aphidicoline glycinate 0.0490935610249067 -0.022070431
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0490935610249067 -0.30835005
NSC 313681 Oxiperomide(USAN) 0.0490935610249067 -0.10928273
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0490935610249067 -0.03906207
Total:80  Current:76    [First] [Prev] [Next] [Last]